HQ Function

Serves as the central hub for Alzheon's research and development, clinical operations, and corporate administration, driving the company's efforts in Alzheimer's drug discovery and development.

Notable Features:

Modern office and lab-supporting facilities within a corporate center, designed to foster collaboration and scientific innovation. Proximity to the Boston/Cambridge biotech ecosystem.

Work Culture:

Alzheon fosters a dynamic, science-driven, and patient-centric work environment. The culture emphasizes innovation, collaboration among team members, and a commitment to making a significant impact in the fight against Alzheimer's disease.

HQ Significance:

The Framingham headquarters is strategically located within the greater Boston biotech hub, providing access to talent, research institutions, and industry partners. It is the core site for Alzheon's efforts to advance ALZ-801 and other pipeline candidates.

Values Reflected in HQ: The headquarters reflects Alzheon's commitment to scientific excellence, operational efficiency, and a focused approach to developing transformative therapies for neurodegenerative diseases.

Location:

Alzheon's global presence is primarily characterized by its international clinical trial operations for its therapeutic candidates, including ALZ-801. The company collaborates with clinical research sites and investigators in North America and Europe. While its corporate headquarters are in the U.S., its reach extends globally through these clinical studies and potential future partnerships for drug development and commercialization.

Street Address:

111 Speen Street, Suite 306

City:

Framingham

State/Province:

Massachusetts

Country:

USA